Overview
Co-operative Insurance is a nationwide life and general insurer serving more than one million policyholders through branches, service points and cooperative distribution partners. The key change is a marked recovery in June-quarter profitability, driven by stronger operating performance rather than revenue growth.
Price performance
COOP closed at LKR 3.30 on 10 September 2026. It fell 10.5% over three months against a 0.9% decline in the ASPI, and the one-year fall was 29.2% while the index gained 2.7%.
The share sits 4.2% of the way through its 52-week range, with 60-day volatility below its own one-year level and trading volume also quieter than its recent norm. The three-year record contains four pullbacks of 15% or more, the deepest reaching 42.1% and not yet recovering. Liquidity is limited: median daily turnover was LKR 1.2 million, so a LKR 1 million order equalled 83.2% of a typical session.
Valuation
At 14.15 times earnings, COOP is modestly above the insurance-sector median of 13.45 times. Its 0.83 times book value is well below the 1.64 times sector median and is the lowest P/B among the ranked insurance peers.
The contrast is that the 0.0% dividend yield offers no current income, while the latest audited ROE was 4.4%. A dividend of LKR 0.05 per share is recorded for FY2024, versus LKR 0.135 in FY2021, with intervening years absent from the record. Against its own history, the current P/B is cheaper than 74% of days since December 2021. The market-wide valuation band is Fairly valued, so the positive stance ends above the starting band on the evidence of improving operations and the unusually low price-to-book multiple.
News and sentiment
Coverage has been unusually heavy, with 3 articles in the last 30 days against a monthly baseline of 1.2. Of 5 material articles over 90 days, 1 was positive and 4 were neutral.
The company redeemed 1.1 million cumulative redeemable preference shares for LKR 16.61 million on 31 August 2026, cancelling them after settlement. A final-dividend disclosure for FY2024 was published on 10 September, while a dividend announced on 2 January 2026 still has no ex-date. Board and management changes were also disclosed during the year.
Financials
June-quarter revenue was broadly flat, rising 0.7% year-on-year, but operating profit increased 126.9% and net profit rose 136.4%. Operating margin widened from 4.0% to 9.1%, while net margin improved from 2.3% to 5.3%. Gross margin was 43.7%; the corresponding prior-year gross margin was not disclosed.
The operating margin was among the company’s best comparable June results, ranking 2 of 4, and the net margin also ranked 2 of 5. Operating profit of LKR 145 million was reduced by LKR 60 million of finance costs, tax and other non-operating items before net profit of LKR 85 million.
Equity increased from LKR 6.02 billion a year earlier to LKR 6.56 billion, while shares outstanding remained at 1.65 billion. The latest audited full year ended December 2025, not the current quarter, and reported a 4.4% ROE; the available data does not provide a reconstructed trailing twelve-month measure.
Risks
The principal risk is that the June profit recovery rests on almost unchanged revenue: sales increased only 0.7%, so future earnings remain sensitive to underwriting and investment performance rather than top-line expansion. The LKR 60 million gap between operating and net profit also shows that a material share of operating earnings was absorbed below the operating line.
Balance-sheet borrowing was LKR 592 million at December 2025, equal to 9.3% of owners’ equity, with operating profit covering finance charges 9.85 times. These are not stretched ratios, but the company’s low 4.4% audited ROE leaves limited room for weaker operating outcomes. As at 10 September 2026, insurance-sector investment conditions were mixed, with lower Treasury bill yields alongside rising secondary bond yields; the company-specific earnings effect is not disclosed.
Outlook
As at 10 September 2026, the next scheduled information event is the filing for the quarter ending 30 September 2026, expected between 12 November 2026 and 2 March 2027. It will determine whether the June operating recovery continued beyond a single quarter.
The pending dividend announcement declared on 2 January 2026 has no ex-date, so its timing remains unknown. One older announced corporate action is already beyond its usual timing window, creating an unresolved disclosure uncertainty rather than an upcoming event.